Regulatory t cells (tregs) in lymphoid malignancies and the impact of novel therapies

HIGHLIGHTS

  • who: Kamira Maharaj from the Osaka University, Japan have published the paper: Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies, in the Journal: (JOURNAL)
  • what: The studies discussed in this section indicate that Tregs harbor altered surface markers Frontiers in Immunology frontiersin.org 10.3389/fimmu.2022.943354 characterized by altered transcriptional and cytokine profiles when compared to healthy donors . This study demonstrated that isolated CLL-derived Tregs killed CLL cells in ex vivo assays, indicating the potential to eliminate malignant cells . The study showed that IL-10 signaling was . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?